Literature DB >> 15167356

Pulmonary hypertension complicating bone marrow transplantation for idiopathic myelofibrosis.

Sadhna Shankar1, John K Choi, Terence S Dermody, David R Head, Nancy Bunin, Robert Iannone.   

Abstract

Idiopathic myelofibrosis is a rare hematologic disorder that is occasionally associated with pulmonary hypertension and has been cured with bone marrow transplantation (BMT). Most cases occur in older adults, but children with similar clinical and pathologic findings have been described. The authors describe a critically ill male infant with idiopathic myelofibrosis and subtle findings suggestive of pulmonary hypertension who was treated with BMT after failing to respond to chemotherapy. After BMT, the patient's clinical course improved in all respects, but he ultimately died of progressive pulmonary hypertension.

Entities:  

Mesh:

Year:  2004        PMID: 15167356     DOI: 10.1097/00043426-200406000-00013

Source DB:  PubMed          Journal:  J Pediatr Hematol Oncol        ISSN: 1077-4114            Impact factor:   1.289


  7 in total

Review 1.  An official American Thoracic Society research statement: noninfectious lung injury after hematopoietic stem cell transplantation: idiopathic pneumonia syndrome.

Authors:  Angela Panoskaltsis-Mortari; Matthias Griese; David K Madtes; John A Belperio; Imad Y Haddad; Rodney J Folz; Kenneth R Cooke
Journal:  Am J Respir Crit Care Med       Date:  2011-05-01       Impact factor: 21.405

2.  Increased tricuspid regurgitant jet velocity by Doppler echocardiography in adult survivors of childhood cancer: a report from the St Jude Lifetime Cohort Study.

Authors:  Gregory T Armstrong; Vijaya M Joshi; Liang Zhu; Deokumar Srivastava; Nan Zhang; Kirsten K Ness; Dennis C Stokes; Matthew T Krasin; James A Fowler; Leslie L Robison; Melissa M Hudson; Daniel M Green
Journal:  J Clin Oncol       Date:  2013-01-07       Impact factor: 44.544

Review 3.  Reversible course of pulmonary arterial hypertension related to bone marrow transplantation.

Authors:  Alisa Limsuwan; Samart Pakakasama; Suradej Hongeng
Journal:  Heart Vessels       Date:  2011-01-07       Impact factor: 2.037

Review 4.  Long-Term Health Effects of Curative Therapies on Heart, Lungs, and Kidneys for Individuals with Sickle Cell Disease Compared to Those with Hematologic Malignancies.

Authors:  Courtney D Fitzhugh; Emmanuel J Volanakis; Ombeni Idassi; Josh A Duberman; Michael R DeBaun; Debra L Friedman
Journal:  J Clin Med       Date:  2022-05-31       Impact factor: 4.964

5.  Successful treatment of pulmonary hypertension with beraprost and sildenafil after cord blood transplantation for infantile leukemia.

Authors:  Nozomu Kawashima; Masanobu Ikoma; Yuko Sekiya; Atsushi Narita; Nao Yoshida; Kimikazu Matsumoto; Tameo Hatano; Koji Kato
Journal:  Int J Hematol       Date:  2012-12-15       Impact factor: 2.490

6.  Myeloproliferative Neoplasms in Children.

Authors:  Inga Hofmann
Journal:  J Hematop       Date:  2015-08-02       Impact factor: 0.196

7.  Infantile Myelofibrosis and Myeloproliferation with CDC42 Dysfunction.

Authors:  Jeffrey M Verboon; Dilnar Mahmut; Ah Ram Kim; Mitsutoshi Nakamura; Nour J Abdulhay; Satish K Nandakumar; Namrata Gupta; Thomas E Akie; Amy E Geddis; Becky Manes; Meghan E Kapp; Inga Hofmann; Stacey B Gabriel; Daryl E Klein; David A Williams; Haydar A Frangoul; Susan M Parkhurst; Genevieve M Crane; Alan B Cantor; Vijay G Sankaran
Journal:  J Clin Immunol       Date:  2020-04-17       Impact factor: 8.317

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.